Study on the effect of 3-acetylpyridine on blood glucose concentration.
D000313:Adrenal Medulla / Q000378:metabolism; D000367:Age Factors; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001921:Brain / Q000009:adverse effects; D004837:Epinephrine / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006943:Hyperglycemia / Q000139:chemically induced; D008112:Liver Glycogen / Q000378:metabolism*; D008464:Mecamylamine / Q000494:pharmacology; D009132:Muscles / Q000378:metabolism*; D009243:NAD / Q000494:pharmacology; D011725:Pyridines / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats
D001786:Blood Glucose; D008112:Liver Glycogen; D011725:Pyridines; D009243:NAD; D008464:Mecamylamine; D006003:Glycogen; D004837:Epinephrine